Schedule 13D ownership disclosure

DOGWOOD THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 92829J203

Event date: 2025-03-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sealbond LimitedReported CIK 0002040446

    Shares: 211,383.00 · Class: 15.9%

  • CK Life Sciences Int'l., (Holdings) Inc.

    Shares: 211,383.00 · Class: 15.9%

  • Conjoint Inc.

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-024579
Form type
SCHEDULE 13D/A
Filer
Dogwood Therapeutics, Inc.
CIK
CIK 1818844
Filed
Mar 17, 2025
Reporting period
Mar 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub